BioSpace News Archive

Pharm Country

Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024, and will present at 8:40 A.M. ET.

June 5, 2024
·
1 min read
Business

Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer

Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.

June 5, 2024
·
4 min read
Business

GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, and Stayhealthy, Inc., a leader in health and wellness technology, are excited to announce a major distribution agreement.

June 5, 2024
·
4 min read
Drug Development

Oricell Presented Long-term Follow-up Data of OriCAR-017 in RRMM at 2024 ASCO Annual Meeting, Highlighting the Sustained Efficacy of GPRC5D CAR-T Therapy

Oricell Therapeutics has presented the two-year long-term follow-up results of OriCAR-017, an open-label Phase I study evaluating GPRC5D-targeted CAR-T therapy in patients with relapsed/refractory multiple myeloma (RRMM).

June 5, 2024
·
4 min read
Lumenis introduces FoLix™, the first FDA-cleared proprietary fractional laser for hair loss treatment

Lumenis Be. Ltd., a leading energy-based medical device company for aesthetic and eye care solutions, is proud to announce the launch of its breakthrough laser system designed to combat hair loss.

June 5, 2024
·
3 min read
Pharm Country

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Insmed Incorporated today announced that management will present in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Conference in Miami on Monday, June 10, 2024, at 10:00 a.m.

June 5, 2024
·
1 min read
BioCapital

REPROCELL USA Receives Funding from Maryland Stem Cell Research Fund (MSCRF)

REPROCELL USA is proud to announce that it has received funding from MSCRF for both proposals it has submitted for the MSCRF’s January 2024 grant cycle.

June 5, 2024
·
2 min read
Drug Development

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1

Harmony Biosciences (Nasdaq: HRMY) presented data from its Phase 2 signal detection study showing that pitolisant reduced excessive daytime sleepiness (EDS) and fatigue in adults with Myotonic dystrophy Type 1 (DM1).

June 5, 2024
·
12 min read
Business

Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year

Celerion, a leading clinical research organization, is pleased to announce it has received a CRO Leadership Award for the ninth time by global biopharmaceutical executives in Life Science Leader’s annual CRO Leadership Awards for 2024.

June 5, 2024
·
2 min read
Pharm Country

Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 11, 2024, at 4:00 p.m. E.T.

June 5, 2024
·
1 min read